Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.85066 | 82 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.7878 | 81 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.82756 | 81 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.47246 | 78 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.76914 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.32361 | 79 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.935 | 83 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.8333 | 81 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.08146 | 83 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.92868 | 82 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.68653 | 80 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.8217 | 81 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.73247 | 81 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.76273 | 81 |